183 related articles for article (PubMed ID: 25430414)
21. Interaction of plasma homocysteine and thyroid hormone concentrations in the pathogenesis of the slow coronary flow phenomenon.
Evrengul H; Tanriverdi H; Enli Y; Kuru O; Seleci D; Bastemir M; Kilic A; Kaftan A; Kilic M
Cardiology; 2007; 108(3):186-92. PubMed ID: 17085937
[TBL] [Abstract][Full Text] [Related]
22. Does cigarette smoking increase plasma urotensin II concentrations?
Gold SJ; Thompson JP; Williams JP; Helm EE; Sadler J; Song W; Ng LL; Lambert DG
Eur J Clin Pharmacol; 2007 Mar; 63(3):253-7. PubMed ID: 17252242
[TBL] [Abstract][Full Text] [Related]
23. Increased thrombolysis in myocardial infarction frame count in patients with myocardial infarction and normal coronary arteriogram: a possible link between slow coronary flow and myocardial infarction.
Yetkin E; Turhan H; Erbay AR; Aksoy Y; Senen K
Atherosclerosis; 2005 Jul; 181(1):193-9. PubMed ID: 15939072
[TBL] [Abstract][Full Text] [Related]
24. Increased high sensitive CRP level and its significance in pathogenesis of slow coronary flow.
Barutcu I; Sezgin AT; Sezgin N; Gullu H; Esen AM; Topal E; Ozdemir R; Kosar F; Cehreli S
Angiology; 2007; 58(4):401-7. PubMed ID: 17652225
[TBL] [Abstract][Full Text] [Related]
25. Plasma atherogenic indices are independent predictors of slow coronary flow.
Afsin A; Kaya H; Suner A; Uzel KE; Bursa N; Hosoglu Y; Yavuz F; Asoglu R
BMC Cardiovasc Disord; 2021 Dec; 21(1):608. PubMed ID: 34930134
[TBL] [Abstract][Full Text] [Related]
26. Plasma urotensin II levels in primary Raynaud's phenomenon and systemic sclerosis.
Gözel N; Karataş A; Yardım M; Kınacı MS; Ulu R; Demircan F; Kılınç F; Öz B; Dönder E; Aydın S; Koca SS
Turk J Med Sci; 2017 Dec; 47(6):1687-1692. PubMed ID: 29306224
[TBL] [Abstract][Full Text] [Related]
27. Association between impaired cutaneous microvascular endothelial function and lectin-like oxidized low-density lipoprotein receptor-1 in patients with coronary slow flow.
Zhao J; Zhang Y; Huang Z; Wu F; Li N; Liang C
Microvasc Res; 2020 May; 129():103984. PubMed ID: 31954703
[TBL] [Abstract][Full Text] [Related]
28. The effects of endothelial dysfunction and inflammation on slow coronary flow.
Arı H; Arı S; Erdoğan E; Tiryakioğlu O; Huysal K; Koca V; Bozat T
Turk Kardiyol Dern Ars; 2010 Jul; 38(5):327-33. PubMed ID: 21200102
[TBL] [Abstract][Full Text] [Related]
29. Effect of Vitamin D and parathyroid hormone levels on the coronary slow-flow phenomenon.
Kalayci B; Karabağ T; Kalaycı S; Erten YT; Köktürk F
Niger J Clin Pract; 2019 Sep; 22(9):1201-1207. PubMed ID: 31489854
[TBL] [Abstract][Full Text] [Related]
30. Blood flow velocity in donor coronary artery depends on the degree and pattern of collateral vessel development: a study using thrombolysis in myocardial infarction frame count method.
Gatzov P; Manginas A; Voudris V; Pavlides G; Genchev GD; Cokkinos DV
Catheter Cardiovasc Interv; 2003 Dec; 60(4):462-8. PubMed ID: 14624422
[TBL] [Abstract][Full Text] [Related]
31. Increased thrombolysis in myocardial infarction (TIMI) frame count in patients with aortic stenosis but normal coronary arteries.
Barutcu I; Turkmen M; Sezgin AT; Gullu H; Esen AM; Karakaya O; Saglam M; Basaran Y
Heart Vessels; 2005 May; 20(3):108-11. PubMed ID: 15912306
[TBL] [Abstract][Full Text] [Related]
32. [Study on the effect of adrenomedulin and urotensin-II on pulmonary hypertension of patients with congenital heart disease].
Wang T; Li SX; Zhang XQ; Gu XH; Song Y; Zhang G; Wu SM
Zhonghua Yi Xue Za Zhi; 2005 Oct; 85(38):2691-5. PubMed ID: 16324296
[TBL] [Abstract][Full Text] [Related]
33. Assessment of the relationship between coronary flow rates and myocardial perfusion abnormality in patients with nonobstructive coronary artery disease: an observational study in cardiac syndrome X and coronary slow flow.
Özde C; Aktüre G; Aytekin S; Sayin AE; Ay EK; Coçkun G; Kaya A; Kayapinar O
Nucl Med Commun; 2019 Nov; 40(11):1122-1129. PubMed ID: 31568270
[TBL] [Abstract][Full Text] [Related]
34. P-wave duration and dispersion in patients with coronary slow flow and its relationship with Thrombolysis in Myocardial Infarction frame count.
Dogan SM; Yildirim N; Gursurer M; Aydin M; Kalaycioglu E; Cam F
J Electrocardiol; 2008; 41(1):55-9. PubMed ID: 16920140
[TBL] [Abstract][Full Text] [Related]
35. The relationship between neutrophil gelatinase-associated lipocalin levels and the slow coronary flow phenomenon.
Aksan G; Soylu K; Aksoy O; Özdemir M; Yanik A; Yuksel S; Gedikli Ö; Gulel O; Sahin M
Coron Artery Dis; 2014 Sep; 25(6):505-9. PubMed ID: 24801557
[TBL] [Abstract][Full Text] [Related]
36. Elevated level of plasma homocysteine in patients with slow coronary flow.
Riza Erbay A; Turhan H; Yasar AS; Ayaz S; Sahin O; Senen K; Sasmaz H; Yetkin E
Int J Cardiol; 2005 Jul; 102(3):419-23. PubMed ID: 16004886
[TBL] [Abstract][Full Text] [Related]
37. Documentation of slow coronary flow by the thrombolysis in myocardial infarction frame count in habitual smokers with angiographically normal coronary arteries.
Erbay AR; Turhan H; Senen K; Yetkin O; Yasar AS; Sezgin AT; Atak R; Cehreli S; Yetkin E
Heart Vessels; 2004 Nov; 19(6):271-4. PubMed ID: 15799173
[TBL] [Abstract][Full Text] [Related]
38. Assessing coronary blood flow with TIMI frame count method in isolated myocardial bridging.
Barutcu I; Sezgin AT; Gullu H; Turkmen M; Esen AM
Angiology; 2007; 58(3):283-8. PubMed ID: 17626981
[TBL] [Abstract][Full Text] [Related]
39. [Relationship between plasma miR-126 and coronary slow flow phenomenon].
Wang L; Wang HN; Zu XL
Zhonghua Yi Xue Za Zhi; 2019 May; 99(17):1323-1327. PubMed ID: 31091580
[No Abstract] [Full Text] [Related]
40. Relationship between serum visfatin levels and coronary slow-flow phenomenon.
Cakmak HA; Aslan S; Yalcin AA; Akturk IF; Yalcin B; Uzun F; Ozturk D; Erturk M; Gul M
Herz; 2015 Sep; 40(6):921-8. PubMed ID: 25939438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
